Establishment of gene-vaccinated skin grafting against Toxoplasma gondii infection in mice.

Abstract:

:Vaccine effects of in vivo gene-vaccinated skin graft were evaluated against Toxoplasma gondii (T. gondii) infection. By using a gene gun, cDNA coding T. gondii SAG1 molecule was intracutaneously vaccinated into C57BL/6 (B6; a susceptible strain), BALB/c (a resistant strain) and (C57BL/6 x BALB/c) F1 (CBF1) mice, and the gene-vaccinated skin of these strains was transplanted to CBF1 mice. Regarding the antibody production against SAG1, CBF1-recipient mice transplanted with the SAG1 gene-vaccinated B6 skin were high responders, whereas CBF1 mice skin grafted with vaccinated skin of both BALB/c and CBF1 mice were low responders. The donor-derived LC/DC migrated to the draining lymph nodes of the recipients from the skin graft within 3 days. The vaccine effect against T. gondii challenge infection was obtained in CBF1 mice which received the skin graft of the SAG1 gene-vaccinated BALB/c mice.

journal_name

Vaccine

journal_title

Vaccine

authors

Saito S,Aosai F,Rikihisa N,Mun HS,Norose K,Chen M,Kuroki T,Asano T,Ochiai T,Hata H,Ichinose M,Yano A

doi

10.1016/s0264-410x(00)00366-2

subject

Has Abstract

pub_date

2001-02-28 00:00:00

pages

2172-80

issue

15-16

eissn

0264-410X

issn

1873-2518

pii

S0264-410X(00)00366-2

journal_volume

19

pub_type

杂志文章

相关文献

VACCINE文献大全